Literature DB >> 23292834

MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.

Jian Sun1, Zhaoli Chen, Xiaogang Tan, Fang Zhou, Fengwei Tan, Yibo Gao, Nan Sun, Xiaohui Xu, Kang Shao, Jie He.   

Abstract

Recently, microRNA-99 family members, such as miR-99a/b and miR-100, have been reported to exhibit abnormal expression in various malignant tumors, but their functions in carcinomas are controversial. In this study, we focused on miR-99a and miR-100, which were determined to be universally downregulated in esophageal squamous cell carcinoma, and investigated their functions and potential mechanisms of action. The downregulation of miR-99a/100 was validated by qRT-PCR in 101 ESCC surgical tissue samples and in 3 ESCC cell lines. The overexpression of miR-99a and miR-100 via the transient transfection of the corresponding precursor molecules inhibited cell proliferation by inducing apoptosis in the ESCC cell lines. To investigate the molecular mechanism of miR-99a/100-induced apoptosis, luciferase reporter assays and Western blots were performed to demonstrate that the overexpression of miR-99a/100 suppressed the expression of mTOR by directly targeting its 3'UTR in a post-transcriptional manner. Clinically, the decreased expression of miR-99a/100 was associated with worse overall survival in ESCC patients. In conclusion, these results indicated that miR-99a and miR-100 inhibited cell proliferation by suppressing mTOR in ESCC cell lines, and therefore, the miR-99a/100-mTOR signaling pathway is a potential therapeutic target for inducing apoptosis to combat ESCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23292834     DOI: 10.1007/s12032-012-0411-9

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  23 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma.

Authors:  Zujian Chen; Yi Jin; Dongsheng Yu; Anxun Wang; Ishrat Mahjabeen; Cheng Wang; Xiqiang Liu; Xiaofeng Zhou
Journal:  Oral Oncol       Date:  2012-03-17       Impact factor: 5.337

3.  MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Authors:  Dong Li; Xingguang Liu; Li Lin; Jin Hou; Nan Li; Chunmei Wang; Pin Wang; Qian Zhang; Peng Zhang; Weiping Zhou; Zhengxin Wang; Guoshan Ding; Shi-Mei Zhuang; Limin Zheng; Wenzhao Tao; Xuetao Cao
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

4.  Antioxidants and cancers of the esophagus and gastric cardia.

Authors:  P Terry; J Lagergren; W Ye; O Nyrén; A Wolk
Journal:  Int J Cancer       Date:  2000-09-01       Impact factor: 7.396

5.  Trends in oesophageal cancer incidence and mortality in Europe.

Authors:  Cristina Bosetti; Fabio Levi; Jacques Ferlay; Werner Garavello; Franca Lucchini; Paola Bertuccio; Eva Negri; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

6.  Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China.

Authors:  Gina D Tran; Xiu-Di Sun; Christian C Abnet; Jin-Hu Fan; Sanford M Dawsey; Zhi-Wei Dong; Steven D Mark; You-Lin Qiao; Philip R Taylor
Journal:  Int J Cancer       Date:  2005-01-20       Impact factor: 7.396

7.  Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma.

Authors:  Yong Guo; Zhaoli Chen; Liang Zhang; Fang Zhou; Susheng Shi; Xiaoli Feng; Baozhong Li; Xin Meng; Xi Ma; Mingyong Luo; Kang Shao; Ning Li; Bin Qiu; Keith Mitchelson; Jing Cheng; Jie He
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

8.  MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Heike Varnholt; Uta Drebber; Falko Schulze; Inga Wedemeyer; Peter Schirmacher; Hans-Peter Dienes; Margarete Odenthal
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

9.  MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.

Authors:  Y-S Zheng; H Zhang; X-J Zhang; D-D Feng; X-Q Luo; C-W Zeng; K-Y Lin; H Zhou; L-H Qu; P Zhang; Y-Q Chen
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

10.  Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.

Authors:  Long Huang; Jia-Xin Lin; Yan-Hong Yu; Mei-Yin Zhang; Hui-Yun Wang; Min Zheng
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

View more
  45 in total

Review 1.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

Review 2.  Tailoring mTOR-based therapy: molecular evidence and clinical challenges.

Authors:  Gaetano Santulli; Hana Totary-Jain
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

3.  An integrated framework for the identification of potential miRNA-disease association based on novel negative samples extraction strategy.

Authors:  Chun-Chun Wang; Xing Chen; Jun Yin; Jia Qu
Journal:  RNA Biol       Date:  2019-01-28       Impact factor: 4.652

4.  MiRNome and transcriptome aided pathway analysis in human regulatory T cells.

Authors:  M H Albert; J Mannert; K K Fleischmann; M Schiemann; P Pagel; I Schmid; T Magg
Journal:  Genes Immun       Date:  2014-05-22       Impact factor: 2.676

5.  miR-125b-5p and miR-99a-5p downregulate human γδ T-cell activation and cytotoxicity.

Authors:  Yuli Zhu; Siya Zhang; Zinan Li; Huaishan Wang; Zhen Li; Yu Hu; Hui Chen; Xuan Zhang; Lianxian Cui; Jianmin Zhang; Wei He
Journal:  Cell Mol Immunol       Date:  2018-02-12       Impact factor: 11.530

Review 6.  Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.

Authors:  Chu Qin; Ru-Yi Huang; Zhao-Xia Wang
Journal:  Tumour Biol       Date:  2015-03-05

Review 7.  MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.

Authors:  J Huang; S-Y Zhang; Y-M Gao; Y-F Liu; Y-B Liu; Z-G Zhao; K Yang
Journal:  Cell Prolif       Date:  2014-06-06       Impact factor: 6.831

8.  Epigenetics in the Pathogenesis of Esophageal Adenocarcinoma.

Authors:  Aparna Kailasam; Sumeet K Mittal; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2014-11-12       Impact factor: 4.689

Review 9.  MicroRNAs in normal and psoriatic skin.

Authors:  Jing Xia; Weixiong Zhang
Journal:  Physiol Genomics       Date:  2013-12-10       Impact factor: 3.107

10.  miR-25 is upregulated before the occurrence of esophageal squamous cell carcinoma.

Authors:  Yaxu Jia; Heng Lu; Cheng Wang; Junjun Wang; Chenyu Zhang; Fangyu Wang; Chunni Zhang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.